Access to medicines and high-quality therapeutics: Global responsibilities for clinical pharmacology

Medical Journal of Australia

Volumn 182, Issue 7, 2005, Pages 322-323

  Day, Richard O ^a   Birkett, Donald J ^b   Miners, John ^c   Shenfield, Gillian M ^e   Henry, David A ^d   Seale, J Paul ^e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Johnson Johnson Research Pty Ltd   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; NON PRESCRIPTION DRUG;

AUSTRALIA; CLINICAL PHARMACOLOGY; CONFERENCE PAPER; CONSUMER; DEVELOPING COUNTRY; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROMOTION; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL SCHOOL; MEDICAL SOCIETY; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PRESCRIPTION; SYMPOSIUM; TRADITIONAL MEDICINE; WORLD HEALTH ORGANIZATION;

EID: 17144387277     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb06728.x     Document Type: Conference Paper

References (1)

1. Laing R, Waning B, Gray A, et al. 25 years of the WHO essential medicines lists: progress and challenges. Lancet 2003; 361:1723-1729.